These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16572927)

  • 21. Nicotinic actions on neuronal networks for cognition: general principles and long-term consequences.
    Poorthuis RB; Goriounova NA; Couey JJ; Mansvelder HD
    Biochem Pharmacol; 2009 Oct; 78(7):668-76. PubMed ID: 19426718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular and cellular mechanisms of action of nicotine in the CNS.
    Barik J; Wonnacott S
    Handb Exp Pharmacol; 2009; (192):173-207. PubMed ID: 19184650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation by nicotine on muscarinic receptor-effector systems.
    Wang H
    Zhongguo Yao Li Xue Bao; 1997 May; 18(3):193-7. PubMed ID: 10072930
    [No Abstract]   [Full Text] [Related]  

  • 24. Oxantel is an N-type (methyridine and nicotine) agonist not an L-type (levamisole and pyrantel) agonist: classification of cholinergic anthelmintics in Ascaris.
    Martin RJ; Clark CL; Trailovic SM; Robertson AP
    Int J Parasitol; 2004 Aug; 34(9):1083-90. PubMed ID: 15313135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resuscitation with 21 or 100% oxygen in hypoxic nicotine-pretreated newborn piglets: possible neuroprotective effects of nicotine.
    Andresen JH; Solberg R; Løberg EM; Munkeby BH; Stray-Pedersen B; Saugstad OD
    Neonatology; 2008; 93(1):36-44. PubMed ID: 17630496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nicotine: smoking gun or magic bullet?
    Pivik RT
    J Psychiatry Neurosci; 1998 Mar; 23(2):91-2. PubMed ID: 9549247
    [No Abstract]   [Full Text] [Related]  

  • 27. Application of nicotine enantiomers, derivatives and analogues in therapy of neurodegenerative disorders.
    Pogocki D; Ruman T; Danilczuk M; Danilczuk M; Celuch M; Wałajtys-Rode E
    Eur J Pharmacol; 2007 Jun; 563(1-3):18-39. PubMed ID: 17376429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persistent rhythmic oscillations induced by nicotine on neonatal rat hypoglossal motoneurons in vitro.
    Lamanauskas N; Nistri A
    Eur J Neurosci; 2006 Nov; 24(9):2543-56. PubMed ID: 17100842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of the hippocampus in mediating emotional responses to nicotine and cannabinoids: a possible neural substrate for functional interactions.
    Viveros MP; Marco EM; Llorente R; Lamota L
    Behav Pharmacol; 2007 Sep; 18(5-6):375-89. PubMed ID: 17762508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nicotine neuroprotection against nigrostriatal damage: importance of the animal model.
    Quik M; O'Neill M; Perez XA
    Trends Pharmacol Sci; 2007 May; 28(5):229-35. PubMed ID: 17412429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacotherapy for tobacco dependence.
    Fant RV; Buchhalter AR; Buchman AC; Henningfield JE
    Handb Exp Pharmacol; 2009; (192):487-510. PubMed ID: 19184660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.
    Rollema H; Chambers LK; Coe JW; Glowa J; Hurst RS; Lebel LA; Lu Y; Mansbach RS; Mather RJ; Rovetti CC; Sands SB; Schaeffer E; Schulz DW; Tingley FD; Williams KE
    Neuropharmacology; 2007 Mar; 52(3):985-94. PubMed ID: 17157884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics.
    Newhouse PA; Potter A; Levin ED
    Drugs Aging; 1997 Sep; 11(3):206-28. PubMed ID: 9303280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reinforcing effects of nicotine microinjections into the ventral tegmental area of mice: dependence on cholinergic nicotinic and dopaminergic D1 receptors.
    David V; Besson M; Changeux JP; Granon S; Cazala P
    Neuropharmacology; 2006 Jun; 50(8):1030-40. PubMed ID: 16580026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. fMRI data predict individual differences of behavioral effects of nicotine: a partial least square analysis.
    Giessing C; Fink GR; Rösler F; Thiel CM
    J Cogn Neurosci; 2007 Apr; 19(4):658-70. PubMed ID: 17381256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The neuronal pathways mediating the behavioral and addictive properties of nicotine.
    Balfour DJ
    Handb Exp Pharmacol; 2009; (192):209-33. PubMed ID: 19184651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydrogen peroxide and antioxidizing enzymes involved in modulation of transient facilitatory effects of nicotine on neurogenic contractile responses in rat gastric fundus.
    Ozger Ilhan S; Sarioglu Y; Vural IM; Dileköz E; Oztürk GS; Ercan ZS
    Eur J Pharmacol; 2008 Jun; 587(1-3):267-72. PubMed ID: 18455720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repeated administration of nicotine attenuates the development of morphine tolerance and dependence in mice.
    Haghparast A; Khani A; Naderi N; Alizadeh AM; Motamedi F
    Pharmacol Biochem Behav; 2008 Feb; 88(4):385-92. PubMed ID: 17915302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in the treatment of Parkinson's disease.
    Singh N; Pillay V; Choonara YE
    Prog Neurobiol; 2007 Jan; 81(1):29-44. PubMed ID: 17258379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nicotine and ethanol interact during adolescence: effects on the central cholinergic systems.
    Ribeiro-Carvalho A; Lima CS; Filgueiras CC; Manhães AC; Abreu-Villaça Y
    Brain Res; 2008 Sep; 1232():48-60. PubMed ID: 18692029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.